153 related articles for article (PubMed ID: 18193241)
1. Mesohepatectomy for hepatocellular carcinoma: a study of 256 patients.
Chen XP; Qiu FZ; Lau WY; Zhang BX; Chen YF; Zhang WG; He SQ
Int J Colorectal Dis; 2008 May; 23(5):543-6. PubMed ID: 18193241
[TBL] [Abstract][Full Text] [Related]
2. Mesohepatectomy for centrally located large hepatocellular carcinoma: Indications, techniques, and outcomes.
Yang LY; Chang RM; Lau WY; Ou DP; Wu W; Zeng ZJ
Surgery; 2014 Nov; 156(5):1177-87. PubMed ID: 25444316
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of central hepatocellular carcinoma in comparison with non-central hepatocellular carcinoma.
Chang CM; Wei CK; Lee CH; Tseng KC; Lin CW; Yin WY
Hepatogastroenterology; 2012; 59(114):492-5. PubMed ID: 21940385
[TBL] [Abstract][Full Text] [Related]
4. Mesohepatectomy for centrally located hepatocellular carcinoma: an appraisal of a rare procedure.
Wu CC; Ho WL; Chen JT; Tang CS; Yeh DC; Liu TJ; P'eng FK
J Am Coll Surg; 1999 May; 188(5):508-15. PubMed ID: 10235579
[TBL] [Abstract][Full Text] [Related]
5. Mesohepatectomy versus extended hemihepatectomy for centrally located hepatocellular carcinoma.
Chen X; Li B; He W; Wei YG; Du ZG; Jiang L
Hepatobiliary Pancreat Dis Int; 2014 Jun; 13(3):264-70. PubMed ID: 24919609
[TBL] [Abstract][Full Text] [Related]
6. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
7. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
9. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
Zhang Q; Shang L; Zang Y; Chen X; Zhang L; Wang Y; Wang L; Liu Y; Mao S; Shen Z
Eur J Gastroenterol Hepatol; 2014 May; 26(5):544-52. PubMed ID: 24614696
[TBL] [Abstract][Full Text] [Related]
10. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the clinical features of HCC following hepatectomy for different stages of HCC.
Ma C; Chi M; Su H; Cheng X; Chen L; Kan Y; Wei W; Huang X; Li Y; Li L; Lin K; Huang Y; Wu Y; Huang X; Huang A; Liu J
Hepatogastroenterology; 2012 Oct; 59(119):2104-11. PubMed ID: 23435129
[TBL] [Abstract][Full Text] [Related]
12. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
13. Mesohepatectomy.
Scudamore CH; Buczkowski AK; Shayan H; Ho SG; Legiehn GM; Chung SW; Owen DA
Am J Surg; 2000 May; 179(5):356-60. PubMed ID: 10930479
[TBL] [Abstract][Full Text] [Related]
14. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
[TBL] [Abstract][Full Text] [Related]
15. The significance of serum AFP cut-off values, 20 and 400 ng/mL in curatively resected patients with hepatocellular carcinoma and cirrhosis might be of difference.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2012 May; 59(115):840-3. PubMed ID: 22469729
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis.
Pacella CM; Francica G; Di Lascio FM; Arienti V; Antico E; Caspani B; Magnolfi F; Megna AS; Pretolani S; Regine R; Sponza M; Stasi R
J Clin Oncol; 2009 Jun; 27(16):2615-21. PubMed ID: 19332729
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of a classification system for centrally located liver tumors in the setting of hepatocellular carcinoma after mesohepatectomy.
Qiu J; Chen S; Wu H; Du C
Surg Oncol; 2016 Dec; 25(4):441-447. PubMed ID: 26987943
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
Zhu Q; Yuan B; Qiao GL; Yan JJ; Li Y; Duan R; Yan YQ
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):418-27. PubMed ID: 26823044
[TBL] [Abstract][Full Text] [Related]
20. Implication of microscopic and macroscopic vascular invasion for liver resection in patients with hepatocellular carcinoma.
Faber W; Stockmann M; Kruschke JE; Denecke T; Bahra M; Seehofer D
Dig Surg; 2014; 31(3):204-9. PubMed ID: 25196847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
